FDA approves Bracco Diagnostics’ CardioGen-82 infusion system
CardioGen-82, a closed system, will enable to produce rubidium Rb 82 chloride injection for intravenous administration
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Oct 20
CardioGen-82, a closed system, will enable to produce rubidium Rb 82 chloride injection for intravenous administration
19 Oct 20
This is the third FDA clearance for the company’s OSSIOfiber Intelligent Bone Regeneration Technology, which uses proprietary bio-integrative…
16 Oct 20
The multi-antigen serology panel will help identify IgG and IgM antibodies the body produces in response to the…
16 Oct 20
LIVMOR Halo is said to be the world's first prescriptible wearable device for continuous heart monitoring
15 Oct 20
The FDA cleared UltraPorator as a manufacturing device for clinical trials of Precigen's investigational UltraCAR-T therapies in compliance…
15 Oct 20
Under the June 6, 2020 version of this EUA, a respirator was authorized if it met any of…
15 Oct 20
The ASTOPAD Patient Warming System is a proven device that has been utilised by hospitals outside the United…
13 Oct 20
AdviseDx SARS-CoV-2 IgM lab-based serology test is designed to run Architect and Alinity platforms
13 Oct 20
Vivid Ultra Edition, AI-Powered Cardiovascular Ultrasound System is intended to reduce diagnostic exam time and boost measurement consistency
12 Oct 20
The assay has been designed for use with a variety of Beckman Coulter analyzers